Ad-sp-VGLL4 |
Tumor-suppressor |
VGLL4 |
G2/M phase arrest; enhanced apoptosis |
Survivin |
Ad5 |
HCC |
(31) |
Ha2bm-d19 |
Transcription enhancer |
a2bm; hypoxia-response elements (HRE) |
Chimeric enhancer/silencer |
AFP |
Ad5 |
HCC |
(32) |
Ad.wnt-E1A (Δ24bp)-TSLC1 |
Tumor-suppressor |
TSLC1 (tumor suppressor in lung cancer1) |
Tumor suppressor gene which 5′ upstream region is methylated |
|
E1A-Δ24bp |
Targeting Wnt and Rb signaling pathway; cancer stem cell |
(33) |
SG655-mGMP |
|
11R-P53; GM-CSF |
11R: penetrating peptide |
hTERT; MCMV |
Ad5 |
Cancer stem cell; |
(32) |
No name |
miRNA |
miR-122 |
Negatively regulate virus replication |
AFP |
Ad5 |
AFP-positive; miR-122deregulated cell |
(34) |
QG511-HA- Melittin |
Cytotoxic gene |
Melittin |
Water-soluble toxic peptide |
Hybrid promoter, hypoxia-response element (HRE)-AFP promoter |
ZD55 |
P53-deficient; AFP positive; |
(35) |
SG505-siFAK |
Short-hairpin RNA |
Hypoxia response element (HRE); siFAK |
Against focal adhesion kinase (FAK) |
hTERT; AFP promoter |
SG505; Ad5 |
HCC |
(36) |
ZD55-XAF1 |
Increase sensitivity |
XAF1 cDNA |
Increase sensitivity |
|
ZD55 |
|
(1) |
GD55 |
Tumor targeting |
GP73 |
Target HCC cells |
GOLPH2 promote |
ZD55 |
Liver cancer cells |
(37) |
AdCN305-SOCS1 |
Tumor-suppressor |
SOC1 gene |
Negative regulator of STAT pathway |
hTERT; deletion of CR2 region |
|
HCC |
(38) |
Ad-XAF-1&TNF-α |
Tumor-suppressor |
Ad-XAF-1&TNF-α |
Inhibit proliferation |
/ |
Ad5 |
HCC |
(39) |
AD55-Mn-SOD |
Tumor-suppressor |
Mn-SOD gene |
Cell toxicity |
AFP |
ZD55 |
Liver cancer cells |
(40) |
SD55-TSLC1 |
Tumor-suppressor |
TSLC1 (tumor suppressor in lung cancer1) |
Tumor suppressor gene which 5′ upstream region is methylated |
Survivin |
ZD55 |
HCC |
(41) |
AFP-D55-SOCS3 |
Tumor-suppressor |
SOCS3 |
Negative regulator of STAT pathway |
AFP |
ZD55 |
AFP-positive |
(42) |
SG600IL-24 |
Cytokine |
IL-24 |
Immune response modulator |
TERTp; HRE |
ZD55 |
HCC |
(43) |
ADCN205 |
Cytokine |
miRNA-34a & IL-24 |
Immune response modulator |
Endogenous E3 promotor; hTERT for E1 |
Ad5-Δ24 |
HCC |
(44) |
Ad-ΔB/TRAIL |
Cytokine |
TRAIL |
/ |
CMV promote E3 |
Ad-ΔB |
HCC |
(45) |
Ad-ΔB/IL-12 |
Cytokine |
IL-12 |
/ |
CMV promote E4 |
Ad-ΔB |
HCC |
(45) |
SG511-CCL5-ODD |
Chemokine |
CCL5 |
Attracts immunocytes; |
hTERT promote E1a, hypoxia-response element (HRE)-AFP promote E1b |
Ad5 |
Tumor cell |
(46) |